MODALIS THERAPEUTICS
Modalis Therapeutics Corporation is an biotech company focusing on developing transformative therapeutics for unmet medical needs using its proprietary technologies on CRISPR and protein engineering platforms. The company has a strong foundation on intellectual property licensed from the University of Tokyo.
MODALIS THERAPEUTICS
Industry:
Biotechnology Health Care Life Science
Founded:
2016-01-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.modalistx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
38.55 M USD
Technology used in webpage:
Google Apps For Business GMO Internet DNS
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Protein Crystal
Protein Crystal is a bio-venture company that develops protein embedding technology.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Investors List
Mizuho Capital
Mizuho Capital investment in Series B - Modalis Therapeutics
Shinsei Capital Partners
Shinsei Capital Partners investment in Series B - Modalis Therapeutics
Pegasus Tech Ventures
Pegasus Tech Ventures investment in Series B - Modalis Therapeutics
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. investment in Series B - Modalis Therapeutics
SBI Investment
SBI Investment investment in Series B - Modalis Therapeutics
SMBC Venture Capital
SMBC Venture Capital investment in Series B - Modalis Therapeutics
CareNet
CareNet investment in Series B - Modalis Therapeutics
UTokyo Innovation Platform
UTokyo Innovation Platform investment in Series B - Modalis Therapeutics
Akira Katayama
Akira Katayama investment in Series B - Modalis Therapeutics
Nippon Venture Capital
Nippon Venture Capital investment in Series A - Modalis Therapeutics
Official Site Inspections
http://www.modalistx.com
- Host name: 111.171.217.34
- IP address: 111.171.217.34
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo